Clinical trial simulation uses mathematical and statistical models to test possible study scenarios before a trial begins. This video explains how clinical trial simulation supports decisions under uncertainty, where it can inform clinical trial design, and why it should not be treated as a prediction of exactly what will happen.
WHAT THIS VIDEO COVERS
• How clinical trial simulation differs from clinical simulation
• How simulation supports early dose planning, escalation rules and sampling schedules
• Why Phase 2 simulation often focuses on proof of concept, endpoints and dose-response uncertainty
• How late-phase simulation can test assumptions around missing data, survival outcomes and dropout
• Why the decision question should drive the model choice
• Common risks, including overfitting sparse data and using unrealistic scenarios
Good simulation work helps teams understand how a proposed design may behave when assumptions change. Its value comes from clear decision questions, credible scenarios, careful documentation, and outputs that translate probabilities into practical trade-offs.
Quanticate’s statistical consultancy team can help you use clinical trial simulation to stress-test assumptions, quantify risk, and support dose, endpoint, and analysis decisions. We’ll review your decision question, available data, and practical constraints, then recommend a proportionate approach with clear assumptions and decision-ready outputs. Request a consultation to discuss your programme and next steps.
Bring your drugs to market with fast and reliable access to experts from one of the world’s largest global biometric Clinical Research Organizations.
© 2026 Quanticate